风险投资部门纷纷展现实力。 - Suppr

Suppr

超能文献

Venture capital arms flex their muscle.

作者信息

Weintraub Karen

出版信息

Cancer Discov. 2012 Mar;2(3):199. doi: 10.1158/2159-8290.CD-ND2012-004. Epub 2012 Jan 19.

DOI:10.1158/2159-8290.CD-ND2012-004

PMID:22585978

Abstract

摘要

相似文献

Venture capital arms flex their muscle.

Cancer Discov. 2012 Mar;2(3):199. doi: 10.1158/2159-8290.CD-ND2012-004. Epub 2012 Jan 19.

Raising venture capital in the biopharma industry.

Drug Discov Today. 2002 Nov 15;7(22):1125-7. doi: 10.1016/s1359-6446(02)02500-x.

Biotech venture capital--it's not too late to be early.

Nat Biotechnol. 2005 Apr;23(4):417-8. doi: 10.1038/nbt0405-417.

The rise of European venture capital for biotechnology.

Nat Biotechnol. 2003 Nov;21(11):1287-91. doi: 10.1038/nbt1103-1287.

The stampede to convertibles.

Nat Biotechnol. 2003 Aug;21(8):855. doi: 10.1038/nbt0803-855.

Japanese firms broaden investment focus to early biotech.

Nat Biotechnol. 2004 Aug;22(8):931-2. doi: 10.1038/nbt0804-931.

Big pharma wants you.

Nat Biotechnol. 2006 Nov;24(11):1317-9. doi: 10.1038/bioent912.

Filters for preparing to meet a venture capitalist.

Nat Biotechnol. 2003 Jul;21 Suppl:BE49-50.

Convincing a venture capitalist to invest in your idea.

Nat Biotechnol. 2003 Jul;21 Suppl:BE45-8.

Does biotech M&A benefit investors?

Nat Biotechnol. 2004 Sep;22(9):1085. doi: 10.1038/nbt0904-1085.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Venture capital arms flex their muscle.

Cancer Discov. 2012 Mar;2(3):199. doi: 10.1158/2159-8290.CD-ND2012-004. Epub 2012 Jan 19.

Raising venture capital in the biopharma industry.

Drug Discov Today. 2002 Nov 15;7(22):1125-7. doi: 10.1016/s1359-6446(02)02500-x.

Biotech venture capital--it's not too late to be early.

Nat Biotechnol. 2005 Apr;23(4):417-8. doi: 10.1038/nbt0405-417.

The rise of European venture capital for biotechnology.

Nat Biotechnol. 2003 Nov;21(11):1287-91. doi: 10.1038/nbt1103-1287.

The stampede to convertibles.

Nat Biotechnol. 2003 Aug;21(8):855. doi: 10.1038/nbt0803-855.

Japanese firms broaden investment focus to early biotech.

Nat Biotechnol. 2004 Aug;22(8):931-2. doi: 10.1038/nbt0804-931.

Big pharma wants you.

Nat Biotechnol. 2006 Nov;24(11):1317-9. doi: 10.1038/bioent912.

Filters for preparing to meet a venture capitalist.

Nat Biotechnol. 2003 Jul;21 Suppl:BE49-50.

Convincing a venture capitalist to invest in your idea.

Nat Biotechnol. 2003 Jul;21 Suppl:BE45-8.

Does biotech M&A benefit investors?

Nat Biotechnol. 2004 Sep;22(9):1085. doi: 10.1038/nbt0904-1085.